DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

SVB Leerink Downgrades BioNTech to Market Perform, Raises Price Target to $31

SVB Leerink analyst Daina Graybosch downgrades BioNTech (NASDAQ:BNTX) from Outperform to Market Perform and raises the price target from $20 to $31.

Benzinga · 01/24/2020 12:56

SVB Leerink analyst Daina Graybosch downgrades BioNTech (NASDAQ:BNTX) from Outperform to Market Perform and raises the price target from $20 to $31.